Immupharma PLC Result of AGM (8788S)
June 28 2018 - 6:16AM
UK Regulatory
TIDMIMM
RNS Number : 8788S
Immupharma PLC
28 June 2018
28 JUNE 2018
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) 596/2014.
2018 ANNUAL GENERAL MEETING - ALL RESOLUTIONS PASSED
ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the
specialist drug discovery and development company, held its AGM
earlier today and is pleased to announce that all resolutions were
duly passed.
-Ends-
For further information please contact:
+ 44 (0) 20
ImmuPharma PLC (www.immupharma.co.uk) 7152 4080
Tim McCarthy, Chairman
Lisa Baderoon, Head of Investor Relations + 44 (0) 7721
Twitter: @immupharma 413496
Northland Capital Partners Limited (NOMAD &
Joint Broker)
David Hignell, Dugald Carlean, Jamie Spotswood,
Corporate Finance +44 (0)20 3861
Rob Rees, Corporate Broking 6625
Bryan, Garnier & Co. (Joint Broker)
Phil Walker, Corporate Finance +44 (0)20 7332
Dominic Wilson, Sales 2500
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RAGFMGZVNRLGRZG
(END) Dow Jones Newswires
June 28, 2018 07:16 ET (11:16 GMT)
Immupharma (LSE:IMM)
Historical Stock Chart
From Apr 2024 to May 2024
Immupharma (LSE:IMM)
Historical Stock Chart
From May 2023 to May 2024